Comparative Study of the Cellular Pharmacodynamics of Tacrolimus in Renal Transplant Recipients Treated with and without Basiliximab

Basiliximab is a recently developed immunosuppressive agent for the prevention of acute allograft rejection in renal transplant recipients. The combination use of basiliximab and a calcineurin inhibitor was suggested to be more effective in comparison to immunosuppressive therapy using calcineurin i...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Kentaro Sugiyama Ph.D., Kazuya Isogai, Satoshi Horisawa, Akira Toyama, Hiroshi Satoh, Kazuhide Saito, Yuki Nakagawa, Masayuki Tasaki, Kota Takahashi, Toshihiko Hirano
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publishing 2012-03-01
Serija:Cell Transplantation
Online dostop:https://doi.org/10.3727/096368911X605493
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki